We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PSNY:NASDAQPolestar Automotive Holding UK Limited Analysis

Data as of 2026-05-27 - not real-time

$22.11

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Polestar’s stock is trading at $22.11, comfortably above its 20‑day SMA (≈$20.54) and 50‑day SMA (≈$19.35), while still below the 200‑day SMA (~$21.85), indicating short‑term momentum but no long‑term trend confirmation. RSI sits at 61, suggesting bullish pressure, and the MACD histogram is positive, reinforcing a bullish technical bias. Volume is on an increasing trend, and the market price is approaching the calculated resistance around $23.28, with support near $16.85 providing a modest downside cushion. However, the fundamentals are starkly negative: gross margin is essentially zero, operating margin is –32%, and net loss widened 131% YoY to $383 million despite a 7% rise in vehicle deliveries. The balance sheet shows over $6.6 billion of debt against just $1.16 billion in cash, and both book value per share and equity‑related ratios are deeply negative. The forward PE is –3.48 and price‑to‑sales is 0.66, while analysts rate the stock “underperform” with a median target of $17.5, well below the current price. The 30‑day volatility is extreme at roughly 62% and the fear‑greed index reads “Extreme Greed,” reflecting heightened market optimism that may be detached from underlying earnings reality.
Given the high beta (~1.0) and exposure to global EV policy shifts, regulatory and geographic risks are material. The combination of aggressive valuation, weak cash‑flow generation, and mounting losses suggests that any upside is speculative and contingent on successful execution of its expansion plan and a turnaround in profitability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (RSI, MACD, rising volume)
  • Proximity to resistance level limiting upside
  • Persistent negative earnings and high debt

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • Continued operating losses and widening net deficit
  • Analyst target price well below current market
  • Elevated volatility and market optimism likely unsustainable

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑term EV market growth potential
  • Strategic expansion plans and new model pipeline
  • Need for significant balance‑sheet improvement to realize upside

Key Metrics & Analysis

Financial Health

Revenue Growth45.40%
Profit Margin-77.08%
P/E Ratio-3.5
ROA-14.66%
P/B Ratio-0.4
Op. Cash Flow$-914988992
Free Cash Flow$-943137856

Technical Analysis

TrendNeutral
RSI61.3
Support$16.85
Resistance$23.28
MA 20$20.54
MA 50$19.35
MA 200$21.85
MACDBullish
VolumeIncreasing
Fear & Greed Index91.05

Valuation

Target Price$17.50
Upside/Downside-20.85%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.01
Volatility61.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.